These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
150 related items for PubMed ID: 2877912
21. A multicenter, double-blind, randomized, placebo-controlled comparison of nocturnal roxatidine in the treatment of active duodenal ulcer disease. Multicenter Roxatidine Cooperative Study Group. Gilinsky NH, Bright-Asare P, Cobert BL, Fitch DD, Lanza FL, Kerr RM, Savitsky JP. Am J Gastroenterol; 1992 Jul; 87(7):847-53. PubMed ID: 1352083 [Abstract] [Full Text] [Related]
22. Comparison of nizatidine and cimetidine as once-nightly treatment of acute duodenal ulcer. Nizatidine Multicenter Duodenal Ulcer Study Group. Cherner JA, Cloud ML, Offen WW, Latz JE. Am J Gastroenterol; 1989 Jul; 84(7):769-74. PubMed ID: 2568086 [Abstract] [Full Text] [Related]
23. 300 mg nizatidine at night versus 300 mg ranitidine at night in patients with duodenal ulcer. A multicentre trial in Europe. Simon B, Cremer M, Dammann HG, Hentschel E, Keohane PP, Mulder H, Müller P, Sarles H. Scand J Gastroenterol Suppl; 1987 Jul; 136():61-70. PubMed ID: 2892257 [Abstract] [Full Text] [Related]
24. Famotidine: proven once-a-day treatment for gastric ulcer. Dammann HG, Walter TA, Hentschel E, Muller P, Simon B. Scand J Gastroenterol Suppl; 1987 Jul; 134():29-33. PubMed ID: 3310200 [Abstract] [Full Text] [Related]
25. [Treatment of duodenal ulcer with famotidine]. Schütze K, Hentschel E, Reichel W, Kerstan E. Wien Med Wochenschr; 1987 Sep 15; 137(17):409-11. PubMed ID: 2891224 [Abstract] [Full Text] [Related]
26. Famotidine: nocturnal administration for gastric ulcer healing. Results of multicenter trials in Austria and Germany. Dammann HG, Walter TA, Hentschel E, Müller P, Simon B. Digestion; 1985 Sep 15; 32 Suppl 1():45-50. PubMed ID: 3905468 [Abstract] [Full Text] [Related]
27. Treatment of duodenal ulceration in the United States. Dyck WP, Cloud ML, Offen WW, Matsumoto C, Chernish SM. Scand J Gastroenterol Suppl; 1987 Sep 15; 136():47-55. PubMed ID: 2892255 [Abstract] [Full Text] [Related]
28. Comparison of the efficacy and safety of ebrotidine in the treatment of duodenal ulcer. A multicentre, double-blind, placebo-controlled phase II study. Gabryelewicz A, Czajkowski A, Skrodzka D, Marlicz K, Luca de Tena F, Aldeguer M, Chantar C, Márquez M, Torres J, Ortiz JA. Arzneimittelforschung; 1997 Apr 15; 47(4A):545-50. PubMed ID: 9205762 [Abstract] [Full Text] [Related]
29. Famotidine therapy for active duodenal ulcers. A multivariate analysis of factors affecting early healing. Reynolds JC. Ann Intern Med; 1989 Jul 01; 111(1):7-14. PubMed ID: 2567589 [Abstract] [Full Text] [Related]
30. [Accelerated healing of ulcus ventriculi by a single evening dose of famotidine. Results of an Austrian-German-Italian multicenter study]. Dammann HG, Barbara L, Bianchi-Porro G, Cheli R, Hentschel E, Müller P, Paoluzzi P, Simon B, Walter TA. Schweiz Med Wochenschr; 1985 Apr 06; 115(14):484-8. PubMed ID: 2859653 [Abstract] [Full Text] [Related]
31. A single nocte dose of famotidine in the treatment of duodenal ulcer. Qureshi H, Ahmad W, Zuberi SJ. J Pak Med Assoc; 1989 Apr 06; 39(4):104-6. PubMed ID: 2568508 [Abstract] [Full Text] [Related]
32. Famotidine. The ACG Committee on FDA-Related Matters with primary authorship by G. Friedman. American College of Gastroenterology. Am J Gastroenterol; 1987 Jun 06; 82(6):504-6. PubMed ID: 2883885 [Abstract] [Full Text] [Related]
33. Single bedtime dose of famotidine: assessment of its antisecretory action by 24-hour intragastric pH monitoring. Savarino V, Picciotto A, Magnolia MR, Scalabrini P, Mela GS, Celle G. J Clin Pharmacol; 1987 Oct 06; 27(10):790-3. PubMed ID: 2892864 [Abstract] [Full Text] [Related]
34. Do anticholinergics interact with histamine H2 receptor antagonists on night intragastric acidity in active duodenal ulcer patients? Fiorucci S, Clausi GG, Farinelli M, Santucci L, Farroni F, Pelli MA, Morelli A. Am J Gastroenterol; 1988 Dec 06; 83(12):1371-5. PubMed ID: 2904218 [Abstract] [Full Text] [Related]
35. Healing and recurrence of active duodenal ulcer with nizatidine. Cloud ML, Offen WW, Matsumoto C, Chernish SM. Clin Pharmacol Ther; 1989 Sep 06; 46(3):310-6. PubMed ID: 2570656 [Abstract] [Full Text] [Related]
36. Famotidine once-a-day in the management of duodenal ulcer: the U.S. placebo-controlled experience. Gitlin N. J Clin Gastroenterol; 1987 Sep 06; 9 Suppl 2():13. PubMed ID: 3624832 [No Abstract] [Full Text] [Related]
37. Famotidine in the short and long-term treatment of duodenal ulcer. Zaterka S, de Paula Castro L, Villalobos JJ, Massuda HK, Eisig JN, Dias Avelar C, Coelho LG, Bettarello A. Acta Gastroenterol Latinoam; 1988 Sep 06; 18(2):115-21. PubMed ID: 3075106 [Abstract] [Full Text] [Related]
38. Nizatidine and ranitidine in the short-term treatment of duodenal ulcer: a cooperative double-blind study of once-daily bedtime administration. Pace F, Colombo E, Ferrara A, Prada A, Rocca F, Bianchi Porro G. Am J Gastroenterol; 1988 Jun 06; 83(6):643-5. PubMed ID: 2897784 [Abstract] [Full Text] [Related]
39. Continuous intravenous infusions of famotidine maintain high intragastric pH in duodenal ulcer. Merki HS, Witzel L, Kaufman D, Kempf M, Neumann J, Röhmel J, Walt RP. Gut; 1988 Apr 06; 29(4):453-7. PubMed ID: 3286384 [Abstract] [Full Text] [Related]
40. A multicentre, randomized, double-blind study comparing nocte famotidine or ranitidine for the treatment of active duodenal ulceration. Alcalá Santaella R, Guardia J, Pajares J, Piqué J, Pita L, Alvárez E, Castellanos P, Guarner L, Ortiz J, Pesquera R. Aliment Pharmacol Ther; 1989 Feb 06; 3(1):103-10. PubMed ID: 2491454 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]